利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

261 条记录 (耗时 0.023 秒)

    STERILIZATION DEVICE
    1.
    发明公开
    STERILIZATION DEVICE 审中-公开

    公开(公告)号：US20230241275A1

    公开(公告)日：2023-08-03

    申请号：US18152107

    申请日：2023-01-09

    申请人： Shenzhen Envicool Health Environment Technology Co., Ltd

    发明人： Fan YANG ,  Jianming WU

    IPC分类号： A61L2/26 ,  A61L2/24 ,  A61L2/14

    CPC分类号： A61L2/26 ,  A61L2/24 ,  A61L2/14 ,  A61L2202/20 ,  A61L2/022

    摘要： A sterilization device includes a shell, an air guide passage, a sterilization module and a blowing device. An opening is formed in a side of the shell to face a handrail of an escalator. The air guide passage disposed in the shell includes an air inlet communicated with an ambient space outside the shell, and an air outlet facing and communicating with the opening. The sterilization module includes a plasma generator disposed in the air guide passage and capable of ionizing air and generating high-energy particles. The blowing device is configured to force air outside the shell into the air guide passage and blow the ionized air and the high-energy particles to the handrail. The sterilization device can accurately sterilize the handrail and realize sterilization based on air ionization, so the cost is low, and a pungent odor is avoided, which brings good experience to passengers riding the escalator.

    ISOLATION FLOATATION CHAMBER
    3.
    发明申请
    ISOLATION FLOATATION CHAMBER 有权
    隔离浮体室

    公开(公告)号：US20150306341A1

    公开(公告)日：2015-10-29

    申请号：US14265336

    申请日：2014-04-29

    申请人： Craig Hoefler

    发明人： Craig Hoefler

    IPC分类号： A61M21/00 ,  A61L2/10 ,  A61L2/18

    CPC分类号： A61M21/0094 ,  A61L2/00 ,  A61L2/022 ,  A61L2/10 ,  A61L2/183 ,  A61L9/00 ,  A61L2202/122 ,  A61L2202/15 ,  A61L2209/14 ,  A61M21/02 ,  A61M2021/0022 ,  A61M2021/0066 ,  A61M2205/11 ,  A61M2205/3368 ,  A61M2209/10 ,  C02F1/001 ,  C02F1/32 ,  C02F1/444 ,  C02F1/78 ,  C02F9/00 ,  C02F2103/42 ,  C02F2201/326 ,  C02F2201/782

    摘要： An isolation chamber and disinfection system. The novel system includes an enclosure for providing a sturdy, lightless and soundproofed environment and for containing a solution for supporting a user in a state of floatation; a disinfection system for disinfecting the solution, the disinfection system including an ultraviolet disinfection system and an ozone injection system; and a pump for removing the solution from the enclosure and circulating it through the disinfection system at a predetermined flow rate. The enclosure is formed from interlocking, foam-insulated panels and lined with a potable liner that holds the solution. In relationship to the isolation chamber, in accordance with the present teachings, an improved method of disinfection is taught using UV radiation with ozone injection. Ozone has a short half-life and leaves substantially no toxic byproducts. Verification of disinfection can be accomplished by monitoring the dissolved ozone, which can be determined accurately utilizing a dissolved ozone sensor system.

    摘要翻译： 隔离室和消毒系统。 该新颖系统包括用于提供坚固，无光和隔音的环境并且用于容纳用于支撑漂浮状态的用户的解决方案的外壳; 用于消毒溶液的消毒系统，包括紫外线消毒系统和臭氧注射系统的消毒系统; 以及用于从外壳去除溶液并将其以预定流速循环通过消毒系统的泵。 外壳由互锁的泡沫绝缘面板形成，内衬有保持溶液的可饮用衬里。 与隔离室有关，根据本教导，使用具有臭氧注射的紫外线辐射来教导改进的消毒方法。 臭氧的半衰期短，基本上没有毒副产物。 消毒验证可以通过监测溶解的臭氧来实现，臭氧可以利用溶解的臭氧传感器系统进行准确的测定。

    METHOD FOR REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS
    5.
    发明申请
    METHOD FOR REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS 有权
    通过LECTIN亲和力HEMODIALYSIS从血液中除去病毒的方法

    公开(公告)号：US20150093289A1

    公开(公告)日：2015-04-02

    申请号：US14490418

    申请日：2014-09-18

    申请人： Aethlon Medical, Inc.

    发明人： Richard H. Tullis

    IPC分类号： A61M1/34 ,  A61L2/02

    CPC分类号： A61M1/3486 ,  A61L2/02 ,  A61L2/022 ,  A61M1/3472

    摘要： The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.

    摘要翻译： 本发明涉及一种使用与具有高甘露糖糖蛋白的高甘露糖表面糖蛋白或其片段的病原体结合的凝集素的方法，其包含高甘露糖糖蛋白，以在体外设置中将其从感染的血液或血浆中除去。 因此，本发明提供一种降低个体病毒载量的方法，其包括以下步骤：从个体获得血液或血浆，使血液或血浆通过多孔中空纤维膜，其中凝集素分子固定在多孔的外部部分 膜，收集直通血液或血浆，并将直通血液或血浆重新输入个体。

    Sterile hyaluronic acid solutions
    6.
    发明授权
    Sterile hyaluronic acid solutions 有权
    无菌透明质酸溶液

    公开(公告)号：US08530641B2

    公开(公告)日：2013-09-10

    申请号：US13564161

    申请日：2012-08-01

    申请人： X. Michael Liu ,  David J. Heiler ,  Thomas Menzel ,  Abbie Brongo ,  Susan E. Burke ,  Karl Cummins

    发明人： X. Michael Liu ,  David J. Heiler ,  Thomas Menzel ,  Abbie Brongo ,  Susan E. Burke ,  Karl Cummins

    IPC分类号： A61K31/728 ,  C08B37/00 ,  C08B37/08

    CPC分类号： A61K31/728 ,  A61L2/022 ,  C08B37/0072

    摘要： Sterilized aqueous solution comprising 0.04% to 0.8% by weight hyaluronic acid with a weight average molecular weight from 0.6 MDa to 3.6 MDa, and one or more buffer components selected from the group consisting of boric acid, sodium borate and sodium dihydrogen phosphate. The aqueous solution also has an ionic strength equivalent to an aqueous concentration of sodium chloride from 4% to 18% by weight of sodium chloride and a pH from 6.4 to 7.2. The solution is also filtered through a filter medium that has an average pore size of 0.25 μm or less to provide a sterilized high salt, hyaluronic acid solution.

    摘要翻译： 含有重量平均分子量为0.6MDa至3.6Mda的0.04％至0.8％重量的透明质酸和一种或多种选自硼酸，硼酸钠和磷酸二氢钠的缓冲成分的灭菌水溶液。 水溶液的离子强度相当于氯化钠的水溶液浓度为4〜18重量％，pH为6.4〜7.2。 该溶液也通过平均孔径为0.25μm或更小的过滤介质过滤以提供无菌的高盐透明质酸溶液。

    Sterile Polymerizable Systems And Kits And Methods Of Their Manufacture And Use
    7.
    发明申请
    Sterile Polymerizable Systems And Kits And Methods Of Their Manufacture And Use 审中-公开
    无菌可聚合系统及其制造和使用方法

    公开(公告)号：US20100226820A1

    公开(公告)日：2010-09-09

    申请号：US12782036

    申请日：2010-05-18

    申请人： Vasanth Prabhu ,  Jeffrey J. Wicklund ,  Erik M. Erbe ,  Anthony M. Wilkes

    发明人： Vasanth Prabhu ,  Jeffrey J. Wicklund ,  Erik M. Erbe ,  Anthony M. Wilkes

    IPC分类号： A61L2/02 ,  A61L2/08 ,  A61L2/16

    CPC分类号： A61L2/081 ,  A61L2/0017 ,  A61L2/0023 ,  A61L2/022 ,  A61L2/04 ,  A61L2/206 ,  A61L2202/24

    摘要： The present invention overcomes the difficulties in the sterilization and delivery of viscous, multi-component compositions that require pre-mixing prior to usage by disclosing a sterile, multi-component, ready-to-use product wherein each component is sterilized independently and then assembled into a sterilized delivery kit. In certain preferred embodiments of the present invention, a sterile, polymerizable system is provided that comprises a plurality of sterile polymerizable monomers, said monomers having been sterilized by passing them through a filter; at least one sterile filler which has been exposed to conditions effective to render said filler sterile, and the sterile monomers and the sterile filler being blended together to form at least one substantially homogeneous blend contained within a sterile delivery vessel. Still other embodiments include a single-use kit that comprises a delivery gun, mix tips, and cartridges that comprise one or more pastes of the present invention that are housed within one or more pouches to ensure sterility of the internal contents.

    摘要翻译： 本发明克服了在使用前需要预混合的粘性多组分组合物的灭菌和输送的困难，所述组合物通过公开无菌的多组分即用型产品，其中各组分被独立灭菌然后组装 成为灭菌的递送试剂盒。 在本发明的某些优选实施方案中，提供了包含多个无菌可聚合单体的无菌可聚合体系，所述单体通过使其通过过滤器被灭菌; 已经暴露于有效使所述填料无菌的条件的至少一种无菌填料，并且将无菌单体和无菌填料混合在一起以形成包含在无菌递送容器内的至少一种基本均匀的混合物。 还有其它实施方案包括一次性使用的试剂盒，其包括输送枪，混合物末端和包含本发明的一种或多种糊剂的药筒，所述药膏包含在一个或多个袋中以确保内部内容物的无菌性。

    Systems and methods for removing viral agents from blood
    8.
    发明授权
    Systems and methods for removing viral agents from blood 有权
    从血液中去除病毒剂的系统和方法

    公开(公告)号：US07374870B2

    公开(公告)日：2008-05-20

    申请号：US11056347

    申请日：2005-02-11

    申请人： Robert E. Herman ,  John Chapman ,  Chong-Son Sun ,  Jean M Mathias ,  Daniel F. Bischof

    发明人： Robert E. Herman ,  John Chapman ,  Chong-Son Sun ,  Jean M Mathias ,  Daniel F. Bischof

    IPC分类号： A01N1/02 ,  A61B19/00

    CPC分类号： A61L2/0011 ,  A61K35/16 ,  A61L2/022 ,  A61L2/08 ,  Y10S435/975

    摘要： Systems and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.

    摘要翻译： 系统和方法处理能够携带污染物的携带血浆的污染物和细胞物质。 系统和方法通过过滤将细胞物质与血浆分离，从而去除携带在细胞内的污染物。 系统和方法将等离子体添加到光敏材料中。 系统和方法将所选波长的辐射发射到等离子体中以激活光活性物质，从而根除细胞物质不会夹带的污染物。